PATENT CLAIM ANALYSIS

Application Number: 16116065
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "217000"]

Abstract:
Described herein are IRE1α inhibitors, compositions containing such inhibitors, and methods of treatment that include administration of such compounds. Exemplary compounds are provided throughout the application.

Claim (Index 16):
The compound of  claim 1 , wherein R 4  is selected from the group consisting of H, optionally substituted C 1 -C 4  alkyl, (optionally substituted C 1 -C 4  alkylene)-OH, hydroxy, optionally substituted aryl, and optionally substituted benzyl.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 96.0
- Lexical Diversity: 1.30435
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15449547', '13697743', '15506380', '14428546', '12892351']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7996142154109113
- 35 USC 102 Novelty (BERT): 0.4963683387895637
- Combined Prediction Score: 0.7692896277487765
- Mean Citation Score: 233.41375
- Max Citation Score: 289.48477
- Similarity Product: 275.249556533823

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test